Key Market Indicators
Finnish demand for antihypertensive medicine will reach nearly $11 million by 2026, according to a new report. Sales of the medication in Finland have grown an average of 2.1% year-on-year since 2003. The country ranked 17th in 2021, behind Chile, which clocked in at $9.79 million. Italy, Spain and Australia took second, third and fourth place, respectively.